ÂÜÀòÂÒÂ×

Rudi Micheletti currently serves as the Director of Biology and Functional Genomics at HAYA Therapeutics, a position held since August 2022. Prior to this, Rudi worked as a Postdoctoral Research Scientist at the University of California San Diego from September 2017 to August 2022 and as a Research Scientist at CHUV | Lausanne University Hospital between November 2011 and December 2016, focusing on long non-coding RNAs in cardiac pathologies. Research experience also includes a role as a Research Assistant at K.U. Leuven and Università di Pavia, where Rudi specialized in gene therapy and the gene regulatory network in skeletal muscle hypertrophy. Rudi holds a PhD in Cardiovascular and Metabolism from the University of Lausanne, a Master’s degree in Medical and Pharmaceutical Biotechnology from Università di Pavia, and a Bachelor’s degree in Medical and Pharmaceutical Biotechnology from Università degli Studi di Milano.